Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closure of Restricted Stock Line

26 Sep 2017 17:31

RNS Number : 8925R
MyCelx Technologies Corporation
26 September 2017
 

 

 26 September 2017

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

Closure of Restricted Stock Line

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, confirms the closure of its restricted line of stock will take effect at 8.00 a.m. on 29 September 2017.

Application has been made to the London Stock Exchange for the transfer of an additional 15,057,638 common shares of $0.025 each ("Common Shares") (the "Additional Shares") from the Company's restricted line of stock with the ticker MYXR (identified under ISIN USU624551078 and SEDOL B56S0J1) (the "Restricted Line") to the Company's unrestricted line of stock with the ticker MYX (identified under ISIN US62847T2024 and SEDOL B8NZQP4) (the "Unrestricted Line").

The Additional Shares are constituted of 15,053,336 Common Shares which have been transferred by shareholders upon expiry of the restricted period under Regulation S of the US Securities Act of 1933 and 4,302 Common Shares under the Omnibus Performance Incentive Plan 2011 block listing which remain unissued. Together with the transfer of the 797,695 Common Shares as announced on 21 September 2017, the Company has applied to the London Stock Exchange for the transfer of a total of 15,855,333 Common Shares from the Restricted Line to the Unrestricted Line at 8.00 a.m. on 29 September 2017.

Trading in the Company's Restricted Line will cease at 8.00 a.m. on 29 September 2017 and, as previously disclosed, all Common Shares currently trading on the Restricted Line will from then on continue to trade on the Unrestricted Line.

From 29 September 2017, all of the 18,770,117 Ordinary Shares will be admitted to trading on the Unrestricted Line.

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - NOMAD and Broker

Andrew Craig

Richard Salmond

 

 

Tel: +44 20 7894 7000

Celicourt Communications

Mark Antelme

Jimmy Lea

 

Tel: +44 20 7520 9266

 

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFMFTMBTTBLR
Date   Source Headline
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNS2012 Preliminary Results
18th Feb 201312:09 pmRNSTransfer of MyCelx Shares between lines of stock
3rd Jan 20137:00 amRNSIssue of Equity/Total Voting Rights
12th Nov 20129:52 amRNSTransfer of MyCelx Shares between lines of stock
8th Oct 20124:11 pmRNSTransfer of MyCelx Shares between lines of stock
13th Sep 20127:00 amRNSAppointment of CFO and Board Director
30th Aug 20127:00 amRNSMyCelx Shares to be Traded on CREST
14th Aug 20127:01 amRNSWebcast interview with CEO
14th Aug 20127:00 amRNSHalf Year Results
8th Aug 20127:00 amRNSContract Win for US$2.35 Million
31st May 20127:00 amRNSRe Contract
10th May 201211:02 amRNSResult of Annual Meeting/Grant of Share Option
9th May 20127:00 amRNSTrading Statement
23rd Apr 20127:00 amRNSPurchase Orders Received for US$2.65 million
17th Apr 20125:34 pmRNSAnnual Financial Report
6th Mar 20127:00 amRNS2011 Preliminary Results
27th Feb 20127:00 amRNSNotice of Preliminary Results
9th Jan 20127:00 amRNSNon-Executive Director Appointment
21st Dec 201110:10 amRNSAccident at Gainesville R&D Site
1st Nov 201112:01 pmRNSPurchase Order Update
1st Nov 20117:00 amRNSPurchase Order and Business Update
27th Sep 20117:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.